Evidence map›Paper›PMID 39136186›Full record

ArticleJMIR mental health2024

Comparison of Use Rates of Telehealth Services for Substance Use Disorder During and Following COVID-19 Safety Distancing Recommendations: Two Cross-Sectional Surveys.

Adrijana Pusnik, Bryan Hartzler, Olivia Vjorn, Beth A Rutkowski, Michael Chaple, Sara Becker, Thomas Freese, Maureen Nichols, Todd Molfenter

Abstract readComparative Study
In one paragraph

Article in JMIR mental health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adrijana Pusnik *Center for Health Enhancement Systems Studies (CHESS), Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, United States.ORCID 0009-0003-2128-0945
Bryan Hartzler *Addictions, Drug & Alcohol Institute, Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, United States.ORCID 0000-0002-7052-2280
Olivia Vjorn *Center for Health Enhancement Systems Studies (CHESS), Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, United States.ORCID 0000-0002-3085-6067
Beth A Rutkowski *Integrated Substance Use and Addiction Programs, Division of Addiction Psychiatry, University of California, Los Angeles, Los Angeles, CA, United States.ORCID 0009-0006-8061-8020
Michael Chaple *New York State Psychiatric Institute, Division of Substance Use Disorders, Columbia University Irving Medical Center, New York City, NY, United States.ORCID 0000-0001-7119-4576
Sara Becker *Center for Dissemination and Implementation Science, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.ORCID 0000-0001-9271-2432
Thomas Freese *Integrated Substance Use and Addiction Programs, Division of Addiction Psychiatry, University of California, Los Angeles, Los Angeles, CA, United States.ORCID 0000-0001-7984-596X
Maureen Nichols *Addiction Research Institute, Steve Hicks School of Social Work, University of Texas at Austin, Austin, TX, United States.ORCID 0000-0001-7865-3376
Todd Molfenter *Center for Health Enhancement Systems Studies (CHESS), Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, United States.ORCID 0000-0003-3033-416X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 social distancing guidelines resulted in a dramatic transition to telephone and video technologies to deliver substance use disorder (SUD) treatment. Before COVID-19, the question was "Will telehealth ever take hold for SUD services?" Now that social distancing guidelines have been lifted, the question is "Will telehealth remain a commonly used care modality?" Objective: The principal purpose of this investigation was to examine the extent to which telehealth use in SUD service settings persisted following the lifting of COVID-19 safety distancing recommendations. Additionally, the study aimed to explore practitioners' perceptions of telehealth convenience and value after its regular implementation during the pandemic. Specifically, the goal of this study was to compare telehealth activity between time intervals: May-August 2020 (during peak COVID-19 safety distancing recommendations) and October-December 2022 (following discontinuation of distancing recommendations). Specifically, we compared (1) telehealth technologies and services, (2) perceived usefulness of telehealth, (3) ease of use of telephone- and video-based telehealth services, and (4) organizational readiness to use telehealth. Methods: An online cross-sectional survey consisting of 108 items was conducted to measure the use of telehealth technologies for delivering a specific set of SUD services in the United States and to explore the perceived readiness for use and satisfaction with telephonic and video services. The survey took approximately 25-35 minutes to complete and used the same 3 sets of questions and 2 theory-driven scales as in a previous cross-sectional survey conducted in 2020. Six of 10 Regional Addiction Technology Transfer Centers funded by the Substance Abuse and Mental Health Services Administration distributed the survey in their respective regions, collectively spanning 37 states. Responses of administrators and clinicians (hereafter referred to as staff) from this 2022 survey were compared to those obtained in the 2020 survey. Responses in 2020 and 2022 were anonymous and comprised two separate samples; therefore, an accurate longitudinal model could not be analyzed. Results: A total of 375 staff responded to the 2022 survey (vs 457 in 2020). Baseline organizational characteristics of the 2022 sample were similar to those of the 2020 sample. Phone and video telehealth utilization rates remained greater than 50% in 2022 for screening and assessment, case management, peer recovery support services, and regular outpatient services. The perceived usefulness of phone-based telehealth was higher in 2022 than in 2020 (mean difference [MD] -0.23; P=.002), but not for video-based telehealth (MD -0.12; P=.13). Ease of use of video-based telehealth was perceived as higher in 2022 than in 2020 (MD-0.35; P<.001), but no difference was found for phone-based telehealth (MD -0.12; P=.11). From the staff's perspective, patients had greater readiness for using telehealth via phone than video, but the staff perceived their personal and organizational readiness for using telehealth as greater for video-based than for phone-based telehealth. Conclusions: Despite lower telephone and video use in 2022 for telehealth services than in 2020, both modalities continue to be perceived positively. Future research may further determine the relative cost and clinical effectiveness of video-based services and thereby help to address some sources of the noted challenges to implementation by SUD organizations.

Indexed as

COVID-19Substance-Related DisordersTelemedicineAdultCross-Sectional StudiesFemaleHumansMalePhysical DistancingSurveys and QuestionnairesCOVID-19substance use disorderstelehealthtelephone counselingvideo counseling

Identifiers

PMID39136186
PMCPMC11331268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.